Special Issue "Monoclonal Antibody"
A special issue of Pharmaceuticals (ISSN 1424-8247).
Deadline for manuscript submissions: closed (31 May 2011)
Dr. Jagadeesh Bayry
Institut National de la Santé et de la Recherche Médicale (INSERM), INSERM Unité 872, Equipe 16 " Immunopathology and therapeutic immunointervention", Centre de Recherche des Cordeliers, 15 Rue de l'Ecole de Médecine, 75006 PARIS, France
Phone: +33 1 44 27 81 93
Fax: +33 1 44 27 81 94
Interests: immunology; autoimmunity; host-pathogen interaction; therapy
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed Open Access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- design and engineering antibody
- autoimmune diseases
- B cells
- T cells
- co-stimulatory molecules
- preclinical evaluation
- experimental models
- infectious diseases
Pharmaceuticals 2010, 3(1), 146-157; doi:10.3390/ph3010146
Received: 15 December 2009; in revised form: 30 December 2009 / Accepted: 8 January 2010 / Published: 12 January 2010| Download PDF Full-text (1675 KB) | Download XML Full-text
Pharmaceuticals 2010, 3(1), 300-322; doi:10.3390/ph3010300
Received: 3 December 2009; in revised form: 12 January 2010 / Accepted: 15 January 2010 / Published: 20 January 2010| Download PDF Full-text (296 KB) | Download XML Full-text
Commentary: In Response to: ‘Impact of Glycosylation on Effector Functions of Therapeutic IgG’ (Pharmaceuticals 2010, 3, 146–157)
Pharmaceuticals 2010, 3(6), 1887-1891; doi:10.3390/ph3061887
Received: 29 April 2010; in revised form: 31 May 2010 / Accepted: 9 June 2010 / Published: 10 June 2010| Download PDF Full-text (146 KB)
Pharmaceuticals 2010, 3(10), 3258-3274; doi:10.3390/ph3103258
Received: 20 September 2010 / Accepted: 18 October 2010 / Published: 18 October 2010| Download PDF Full-text (133 KB)
Article: Monoclonal Antibodies against Small Molecule Natural Products and Their Applications, Eastern Blotting and Knockout Extract
Pharmaceuticals 2011, 4(7), 950-963; doi:10.3390/ph4070950
Received: 27 April 2011; in revised form: 3 June 2011 / Accepted: 8 June 2011 / Published: 28 June 2011| Download PDF Full-text (269 KB) | Download XML Full-text
Last update: 19 July 2013